Guanylate Cyclase-C Agonists  market research report identifies, estimates, and analyses the emerging trends along with major drivers, restraints, challenges and opportunities in the market. The research and analysis carried out in this report helps clients to predict investment in an emerging market, expansion of market share or success of a new product with the help of global market research analysis. The use of proven tools such as SWOT analysis and Porter’s Five Forces analysis are very helpful in creating such a top-notch Guanylate Cyclase-C Agonists  market report. Estimations of CAGR values, market drivers and market restraints helps businesses decide upon several strategies.
 
Data Bridge Market Research analyses that the guanylate cyclase-C agonists? market was valued at USD 546 million in 2021 and is expected to reach USD 837.94 million by 2029, registering a CAGR of 5.50% during the forecast period of 2022 to 2029
 
 
Constipation associated with irritable bowel syndrome (IBS) and chronic constipation of unclear cause (idiopathic constipation) in adults are treated with guanylate cyclase-C agonists. IBS is characterized by stomach pain or cramps, bloating, and infrequent or difficult bowel movements. Guanylate cyclase-C agonists are prescription pharmaceuticals that can be taken alone or in combination with other drugs.
 
Guanylate Cyclase-C Agonists? Market Dynamics
 
Drivers
 
  • Increasing incidences of gastrointestinal disorders
The rising incidences of gastrointestinal disorders such as chronic idiopathic constipation and irritable bowel syndrome is anticipated to influence the guanylate cyclase-C agonists? market's growth. Growing smoking addiction and surging alcohol consumption are some of the causes of gastrointestinal disorders.
 
  • Increasing investment for healthcare infrastructure
Another significant factor influencing the growth rate of guanylate cyclase-C agonists? market is the rising healthcare expenditure which helps in improving its infrastructure.
 
Furthermore, rising initiatives by public and private organizations to spread awareness will expand the guanylate cyclase-C agonists? market. Additionally, high disposable income and sedentary lifestyle of people will result in the expansion of guanylate cyclase-C agonists? market. Along with this, rising geriatric population and favourable reimbursement policies will enhance the growth rate of the market.
 
Some of the major players operating in the guanylate cyclase-C agonists? market are:
 
  • Abbott (US)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Mylan N.V. (US)
  • Teva Pharmaceutical Industries Ltd.( Israel)
  • Sanofi (France)
  • Novartis AG (Switzerland)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Pfizer Inc. (US)
  • GlaxoSmithKline plc (UK)
  • AstraZeneca (UK)
  • Johnson & Johnson Private Limited (US)
  • Boehringer Ingelheim International GmbH. (Germany)
 
 
Browse Trending Reports:
 
 
 
 
 
 
 
About Data Bridge Market Research:
 
An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.
 
Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.
 
Contact Us: -
 
Data Bridge Market Research
 
US: +1 888 387 2818
 
United Kingdom: +44 208 089 1725
 
Hong Kong: +852 8192 7475
 
Email: – [email protected]